For context, semaglutide and tirzepatide do not produce dysesthesia at clinically significant rates, though a recent paper in PMC examined allodynia and dysesthesia reports across GLP-1 medications more broadly
Differences between semaglutide and CDA-HFD vehicle were assessed using Welchs unpaired t-test, two tailed
Whether this is a direct action of metformin on GLP-1 release, and whether some of the glucose-lowering effect of metformin occurs due to GLP-1 release, is unknown
Food and Drug Administrations compassionate use program, according to STAT News
A small 2024 study published in Endocrine Abstracts showed that semaglutide was more effective than testosterone replacement therapy in improving body composition and increasing testosterone for men with type 2 diabetes
GLP-1 weight loss medications are approved for specific patient populations based on BMI and health conditions